Multiple Hospitalizations and Disease Duration Emerge as Major Risk Factors for Gallstones in Crohn's Disease
核心洞察
PROSPERO (搜索) meta-analysis reveals patients with Crohn's disease (搜索) who experience more than two hospitalizations face over four times higher risk of developing gallstones, according to new research findings.
The study identified a 14.9% pooled prevalence of gallstone disease (搜索) in Crohn's patients, with long-term disease duration exceeding 15 years tripling the risk of gallstone formation.
Multiple total parenteral nutrition instances, repeated corticosteroid (搜索) treatments, and prior bowel resection surgeries were identified as significant contributors to gallstone development in Crohn's disease (搜索) patients.
A comprehensive meta-analysis has unveiled critical risk factors for gallstone development in patients with Crohn's disease (搜索), with frequent hospitalizations and extended disease duration emerging as primary concerns. The PROSPERO (搜索) study, published in Digestive Diseases and Sciences, analyzed data from three major databases through September 2023 to create an evidence-based risk assessment framework.
Prevalence and Risk Assessment
The meta-analysis, encompassing 11 studies, established a pooled gallstone disease (搜索) prevalence of 14.9% among Crohn's disease (搜索) patients, with individual studies reporting rates between 9.8% and 29.8%. This prevalence significantly exceeds the general population's annual incidence of 0.60% to 1.39%.
Patients with more than two hospitalizations demonstrated the highest risk elevation, with an odds ratio of 4.26 (P < .00001). Disease duration exceeding 15 years also emerged as a substantial risk factor, tripling the likelihood of gallstone formation (OR, 3.01; P < .0001).
Key Clinical Risk Factors
Multiple treatment-related factors showed significant associations with gallstone development:
- Multiple total parenteral nutrition (TPN) episodes: OR 2.93 (P < .0003)
- History of TPN usage: OR 2.66 (P < .008)
- Three or more corticosteroid treatments: OR 2.65 (P = .0006)
- Previous bowel resection surgeries: OR 2.50 (P < .00001)
Disease characteristics also played a crucial role, with ileocecal Crohn's disease (搜索) (OR 1.93; P = .01) and immunomodulator (搜索) therapy (OR 1.94; P = .02) showing moderate risk associations.
Disease Location Impact
The study revealed that patients with ileocolic Crohn's disease (搜索) (L3) faced an elevated gallstone risk (OR 1.38; P = .03). However, disease limited to the ileum showed no significant impact on gallstone development (OR 0.89; P = .42).
Non-Significant Factors
Several commonly suspected risk factors showed minimal influence:
- Gender differences proved insignificant (OR 1.16; P = .43)
- Body mass index, whether high or low, demonstrated no meaningful impact (OR 1.39; P = .34)
Clinical Implications
These findings provide healthcare providers with valuable insights for identifying high-risk patients and implementing preventive strategies. The research particularly emphasizes the need for vigilant monitoring of patients with multiple hospitalizations or long-standing disease.
Study Limitations
The meta-analysis faced several constraints, including:
- Reliance on observational studies, limiting causal relationship establishment
- Potential publication bias affecting prevalence analysis
- Geographic limitations, with most data sourced from European studies
- Limited representation from Asian and African populations
The researchers advocate for additional multicenter studies to address these limitations and further explore gallstone risk factors in diverse populations with Crohn's disease (搜索).